Search global stocks & ETFs...Ctrl K
Learn Mode
BSX logo
Boston Scientific CorpBSX
$46.91
-$0.26 (-0.551%)
at close
$46.93
$0.02 (0.033%)
after hours · 11:49 PM
General
Scores
Financials & KPIs
Dividends
Analyst
Insider
Updates
BSX
Stock Profile
Market Cap
$69.72B
Industry
Health Care
EPS (TTM)
$2.38
P/E (TTM)
19.56
Div & Yield
--
FCF Payout Ratio
--
P/S (TTM)
3.38
P/B
2.70
Revenue Growth (TTM)
17.44%
EPS CAGR (3Y)
59.09%
Diluted Shares
1.50B
Ex-Dividend
--
Next Earnings
07-29
Forward P/E
13.51
Payout Ratio
--
P/FCF (TTM)
20.08
FCF Yield
4.98%
Earnings Yield
5.11%
Revenue CAGR (3Y)
16.47%
Recommended Metric
4.08
Good
Boston Scientific Corp has grown revenue at 17.44% over the past year, which is strong growth. Also, it has seen its operating income increase by 25.97% over the past year, which suggests its operations are becoming much more profitable.
Valuation Score
Key Score
1.00
Very Bad
Management
3.00
Average

Growth
1.00
Very Bad

Profitability
5.00
Very Good
Fin. Health
3.00
Average

Dividends
--
--

Analyst
1.00
Very Bad
Revenue
Earnings
Free Cash Flow
Insider Transactions
Explore Insider Tab ›
Buy Transactions
Sell Transactions
Price Targets & Ratings
View Analysis
1-year price targets, ending May 11, 2027
Current
$46.91
Baseline
High
$123.90
164.12%
Avg
$88.87
89.44%
Low
$60.60
29.18%
Analyst Ratings based on 40 Analysts
Strong Buy
12
30%
Buy
20
50%
Hold
8
20%
Sell
0
00%
Strong Sell
0
00%
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. The company is headquartered in Marlborough, Massachusetts and currently employs 59,000 full-time employees. The firm's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.Read More

IPO Date
1992-05-19

Industry
Health Care

Total Employees
59,000

Exchange
New York Stock Exchange, Inc.

Reporting Currency
USD

GICS
Health Care Equipment & Supplies

GICS Sub
Health Care Equipment

GICS Sector
Health Care

GICS Group
Health Care Equipment & Services
News100%Bullish

Meet the Medtech Stock Wall Street Thinks Will Soar 65% Over the Next 12 Months
3h
Yahoo
Meet the Medtech Stock Wall Street Thinks Will Soar 65% Over the Next 12 Months thumbnail

FDA clears Penumbra’s Thunderbolt thrombectomy platform for stroke
16h
Yahoo
FDA clears Penumbra’s Thunderbolt thrombectomy platform for stroke thumbnail

Boston Scientific: The Market Is Pricing A Broken Compounder-We See A Reset One
20h
SeekingAlpha
Boston Scientific: The Market Is Pricing A Broken Compounder-We See A Reset One thumbnail

Penumbra’s FDA nod for clot removal tech a win for Boston Scientific
20h
Yahoo
Penumbra’s FDA nod for clot removal tech a win for Boston Scientific thumbnail

Elfun Trusts Exits Abbott Laboratories, Impacting Portfolio by -1.97%
1d
Yahoo
Elfun Trusts Exits Abbott Laboratories, Impacting Portfolio by -1.97% thumbnail

BTIG Remains Bullish On Boston Scientific (BSX); Check Out What It Says About The Stock
1d
Yahoo
BTIG Remains Bullish On Boston Scientific (BSX); Check Out What It Says About The Stock thumbnail

Boston Scientific (BSX) Stock Moves -1.27%: What You Should Know
2d
Yahoo
Boston Scientific (BSX) Stock Moves -1.27%: What You Should Know thumbnail

[Latest] Global Gastrointestinal Endoscopy Devices Market Size/Share Worth USD 19.6 Billion by 2035 at a 5.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
2d
Yahoo
[Latest] Global Gastrointestinal Endoscopy Devices Market Size/Share Worth USD 19.6 Billion by 2035 at a 5.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis) thumbnail

Is Boston Scientific (BSX) One of the Best Healthcare Stocks to Buy With the Highest Upside Potential?
3d
Yahoo
Is Boston Scientific (BSX) One of the Best Healthcare Stocks to Buy With the Highest Upside Potential? thumbnail

Boston Scientific to build Indiana distribution center
4d
Yahoo
Boston Scientific to build Indiana distribution center thumbnail

Boston Scientific (BSX) Initiates $2B Accelerated Share Repurchase Agreement
5d
Yahoo
Boston Scientific (BSX) Initiates $2B Accelerated Share Repurchase Agreement thumbnail

Medtronic: The Turnaround Is Quietly Working
1w
SeekingAlpha
Medtronic: The Turnaround Is Quietly Working thumbnail

Is Boston Scientific Corporation (BSX) One of the Top Cheap Stocks With Strong Buy Ratings on Wall Street?
1w
Yahoo
Is Boston Scientific Corporation (BSX) One of the Top Cheap Stocks With Strong Buy Ratings on Wall Street? thumbnail

How Investors May Respond To Boston Scientific (BSX) Strong Q1 Beat But Cut Guidance On Watchman Growth
1w
Yahoo
How Investors May Respond To Boston Scientific (BSX) Strong Q1 Beat But Cut Guidance On Watchman Growth thumbnail

Boston Scientific (BSX) Rises Higher Than Market: Key Facts
1w
Yahoo
Boston Scientific (BSX) Rises Higher Than Market: Key Facts thumbnail

Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet
1w
Yahoo
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet thumbnail

Jim Cramer Says “No One Disputes the Science and Commercial Smarts of Abbott”
1w
Yahoo
Jim Cramer Says “No One Disputes the Science and Commercial Smarts of Abbott” thumbnail

Truist Securities Maintains Buy on Boston Scientific, Lowers Price Target to $64
1w
Benzinga
Truist Securities Maintains Buy on Boston Scientific, Lowers Price Target to $64 thumbnail

Investors should take some money off the table, says MAI Capital's Chris Grisanti
1w
CNBC
Investors should take some money off the table, says MAI Capital's Chris Grisanti thumbnail

BTIG Maintains Buy on Boston Scientific, Lowers Price Target to $65
1w
Benzinga
BTIG Maintains Buy on Boston Scientific, Lowers Price Target to $65 thumbnail

Can ISRG's Digital Roadmap Unlock the Next Phase of Robotic Surgery?
1w
Yahoo
Can ISRG's Digital Roadmap Unlock the Next Phase of Robotic Surgery? thumbnail

3 S&P 500 Stocks with Solid Fundamentals
1w
Yahoo
3 S&P 500 Stocks with Solid Fundamentals thumbnail

How A Quiet Reset Is Shaping The Boston Scientific (BSX) Investment Story
1w
Yahoo
How A Quiet Reset Is Shaping The Boston Scientific (BSX) Investment Story thumbnail

FRACTURE IDE Success Adds Clinical Support To Boston Scientific Valuation Case
1w
Yahoo
FRACTURE IDE Success Adds Clinical Support To Boston Scientific Valuation Case thumbnail

Peripheral Vascular Devices Market by Type, End User - Global Forecast to 2031
1w
Yahoo
Peripheral Vascular Devices Market by Type, End User - Global Forecast to 2031 thumbnail

Boston Scientific Stock: Is BSX Underperforming the Healthcare Sector?
1w
Yahoo
Boston Scientific Stock: Is BSX Underperforming the Healthcare Sector? thumbnail

Why Did BSX, LOW, CAG Fall To 52-Week Lows Today?
1w
Yahoo
Why Did BSX, LOW, CAG Fall To 52-Week Lows Today? thumbnail

Spotting Winners: Boston Scientific (NYSE:BSX) And Medical Devices & Supplies - Diversified Stocks In Q1
1w
Yahoo
Spotting Winners: Boston Scientific (NYSE:BSX) And Medical Devices & Supplies - Diversified Stocks In Q1 thumbnail

Why These Three Big Buybacks Are Sending Very Different Signals to Investors
1w
Yahoo
Why These Three Big Buybacks Are Sending Very Different Signals to Investors thumbnail

Jim Cramer Comments On Boston Scientific and Other Medical Equipment Makers
1w
Yahoo
Jim Cramer Comments On Boston Scientific and Other Medical Equipment Makers thumbnail

Jim Cramer on Medtronic: “This Long-Term Winner’s Become a Short-Term Loser”
1w
Yahoo
Jim Cramer on Medtronic: “This Long-Term Winner’s Become a Short-Term Loser” thumbnail

Wolfe Research Downgrades Boston Scientific Corporation (BSX) To Peer Perform
1w
Yahoo
Wolfe Research Downgrades Boston Scientific Corporation (BSX) To Peer Perform thumbnail

TFX Stock Setup: Valuation, Leverage, and a Neutral Zacks Rank
1w
Yahoo
TFX Stock Setup: Valuation, Leverage, and a Neutral Zacks Rank thumbnail

Canaccord Genuity Maintains Buy on Boston Scientific, Lowers Price Target to $70
1w
Benzinga
Canaccord Genuity Maintains Buy on Boston Scientific, Lowers Price Target to $70 thumbnail

CDT May 2026 - 1999 Called, They Want Their Stock Market Back
1w
SeekingAlpha
CDT May 2026 - 1999 Called, They Want Their Stock Market Back thumbnail

Is Medtronic Stock Underperforming the Nasdaq?
1w
Yahoo
Is Medtronic Stock Underperforming the Nasdaq? thumbnail

Why Did BSX, LI, ROL Stocks Fall To 52-Week Lows On Friday?
1w
Yahoo
Why Did BSX, LI, ROL Stocks Fall To 52-Week Lows On Friday? thumbnail

Boston Scientific Corp (NYSE:BSX): A Decent Value Play with Strong Fundamentals and an Attractive Valuation
1w
ChartMill
Boston Scientific Corp (NYSE:BSX): A Decent Value Play with Strong Fundamentals and an Attractive Valuation thumbnail

Boston Scientific (BSX) Valuation Reset After Watchman Growth Concerns And Intensifying Competition
1w
Yahoo
Boston Scientific (BSX) Valuation Reset After Watchman Growth Concerns And Intensifying Competition thumbnail

Boston Scientific Corporation (BSX) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
2w
SeekingAlpha
Boston Scientific Corporation (BSX) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript thumbnail

Jim Cramer looks ahead to next week's market game plan
2w
CNBC
Jim Cramer looks ahead to next week's market game plan thumbnail

1 of Wall Street’s Favorite Stocks to Consider Right Now and 2 We Brush Off
2w
Yahoo
1 of Wall Street’s Favorite Stocks to Consider Right Now and 2 We Brush Off thumbnail

Unusual Options Activity Points to Boston Scientific Stock as a Hot M&A Target
2w
Yahoo
Unusual Options Activity Points to Boston Scientific Stock as a Hot M&A Target thumbnail

Teleflex Divestitures: What Investors Should Watch in 2026
2w
Yahoo
Teleflex Divestitures: What Investors Should Watch in 2026 thumbnail

Best Buy downgrade, Dell upgraded: Wall Street's top analyst calls
2w
Yahoo
Best Buy downgrade, Dell upgraded: Wall Street's top analyst calls thumbnail

Wolfe Research Downgrades Boston Scientific (BSX)
2w
Fintel
Wolfe Research Downgrades Boston Scientific (BSX) thumbnail

BSX vs. ABT: Which Medical Stock Has More Upside Potential?
2w
Yahoo
BSX vs. ABT: Which Medical Stock Has More Upside Potential? thumbnail

Wolfe Research cuts Boston Scientific rating as key growth drivers falter
2w
Yahoo
Wolfe Research cuts Boston Scientific rating as key growth drivers falter thumbnail

Is Abbott Laboratories Stock Underperforming the Dow?
2w
Yahoo
Is Abbott Laboratories Stock Underperforming the Dow? thumbnail

This Analyst Turns Bearish On Gap; Here Are Top 3 Downgrades For Friday
2w
Benzinga
This Analyst Turns Bearish On Gap; Here Are Top 3 Downgrades For Friday thumbnail
Scroll for more · 50 articles